BRAIN TUMOUR
The special field of interest of this group is the preclinical and clinical testing of new radiopharmaceuticals for the diagnosis of brain tumours (i.e., gliomas and metastasis) using positron emission tomography (PET) and correlated with magnetic resonance imaging (MRI).
